Remove Finance Remove Pharmaceuticals Remove ROI
article thumbnail

The “Maximize Profits” Trap in Decision Making

Harvard Business

Imagine, for example, that you’re a pharmaceutical CEO deciding whether to recall a new drug. “When we work on making our devices accessible by the blind,” he added, “I don’t consider the bloody ROI.” With gray area problems, you have to look hard at the economics and look past the economics.

ROI 70
article thumbnail

The Questions Executives Should Ask About 3D Printing

Harvard Business

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. Carmakers have started using 3D technology to produce parts. And last year saw the first demonstration of a digital printer producing multilayer, standards-based circuit boards. IP piracy will be another major complication.